Abstract

Gouty arthritis is characterized by the deposition of monosodium urate (MSU) within synovial joints and tissues due to increased urate concentrations. Here, we elucidated the role of the natural compound cichoric acid (CA) on the MSU crystal-stimulated inflammatory response. The THP-1-derived macrophages (THP-Ms) were pretreated with CA and then stimulated with MSU suspensions. The protein levels of p65 and IκBα, the activation of the NF-κB signaling pathway by measuring the expression of its downstream inflammatory cytokines, and the activity of NLRP3 inflammasome were measured by western blotting and ELISA. CA treatment markedly inhibited the degradation of IκBα and the activation of NF-κB signaling pathway and reduced the levels of its downstream inflammatory genes such as IL-1β, TNF-α, COX-2, and PGE2 in the MSU-stimulated THP-M cells. Therefore, we infer that CA effectively alleviated MSU-induced inflammation by suppressing the degradation of IκBα, thereby reducing the activation of the NF-κB signaling pathway and the NLRP3 inflammasome. These results suggest that CA could be a novel therapeutic strategy in averting acute episodes of gout.

Highlights

  • Gout, one of the most severe and common forms of inflammatory arthritis, results from hyperuricemia and deposition of monosodium urate (MSU) crystals in articular joints and periarticular tissues [1]

  • We show that cichoric acid (CA) can inhibit MSU crystalstimulated inflammation in THP-1-derived macrophages (THP-Ms) cells by diminishing the levels of IL-1β, TNF-α, COX-2, prostaglandin E2 (PGE2), cAMP, and PKA by inhibiting the IκBα degradation and reducing the activation of the nuclear factor-κB (NF-κB) signaling pathway and NLRP3 inflammasome

  • In our preliminary experiment, we have evaluated the polarization of different concentrations treated THP-M cells and the result showed that the dose of CA was 1–10 μg/ml; there was no significant effect on the polarization of macrophages, and when the dose of CA was more than or equal to 30 μg/ml, the polarization of macrophages was significantly reduced

Read more

Summary

Introduction

One of the most severe and common forms of inflammatory arthritis, results from hyperuricemia and deposition of monosodium urate (MSU) crystals in articular joints and periarticular tissues [1]. Erefore, it is crucial to develop novel agents for the treatment of gouty arthritis. Gout is triggered by the deposition of monosodium urate (MSU) crystals in and around joints where macrophages play a critical role in its occurrence, growth, and regression [4, 5]. Prostaglandin E2 (PGE2), converted from arachidonic acid (AA) by cyclooxygenase (COX), contributes to the production of IL-1β, an important mediator in gout [8,9,10]. Erefore, several cyclooxygenase-2 (COX-2) inhibitors have been clinically used to treat gouty arthritis [11].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call